According to a new report, published by KBV research, The Global Thoracic Surgery Devices Market size is expected to reach $998.1 million by 2030, rising at a market growth of 6.1% CAGR during the forecast period.
The Wedge Resection segment is showcasing a CAGR of 6.4% during (2023 - 2030). Wedge resection is commonly used to treat small, peripheral lung nodules or lesions. The demand for specialized devices, such as precision cutting instruments, staplers, and hemostatic devices, has increased with the rising incidence of early-stage lung cancer and the emphasis on early detection. With the focus on early detection and precise localization of lung nodules, advanced imaging technologies, such as navigational bronchoscopy and intraoperative imaging devices, have become essential. These devices aid in the precise localization of nodules and guide the surgeon during wedge resection.
The Forceps segment is leading the Global Thoracic Surgery Devices Market, by Product in 2022 thereby achieving a market value of $262.3 Million by 2030. During thoracic surgery, forceps are crucial for gently grasping and holding delicate tissues, such as the lung, pleura, or esophagus. This allows surgeons to maneuver tissues for better visibility and precise surgical access. In the case of tumor resections, forceps are used to grasp and remove tumor tissue while minimizing damage to surrounding healthy tissue. They provide the control needed to ensure complete tumor excision. During suturing and stapling procedures, forceps hold and manipulate needles, sutures, and staples.
The Ambulatory Surgical Centers segment has shown the high growth rate of 6.3% during (2023 - 2030). Ambulatory surgical centers (ASCs) primarily focus on providing outpatient surgical services. They perform many procedures that can be managed outside traditional hospital settings, including thoracic surgeries. This trend results in a higher demand for thoracic surgery devices, as these centers require the necessary tools to conduct safe and effective procedures. Many ASCs are early adopters of minimally invasive surgical techniques commonly employed in thoracic surgeries. These techniques often require specialized devices and instruments, such as minimally invasive staplers and thoracoscopes, contributing to market growth.
The North America region dominated the Global Thoracic Surgery Devices Market, by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $365.5 Million by 2030. The Europe market is anticipated to grow at a CAGR of 5.9% during (2023 - 2030). Additionally, The Asia Pacific market would witness a CAGR of 6.8% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/thoracic-surgery-devices-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, Cardiotrack, Intuitive Surgical, Inc., Richard Wolf GmbH, Grena Ltd., Dextera Surgical Inc. (Aesculap Inc.), Teleflex, Inc., Medela AG, LivaNova PLC, and Sklar Corporation.
By Surgery Type
By Product
By End-use
By Geography
Companies Profiled
Unique Offerings 
